×
About 1,063 results

ALLMedicine™ Hypogammaglobulinemia Center

Research & Reviews  403 results

Infectious complications in relapsed refractory multiple myeloma patients after BCMA Ca...
https://doi.org/10.1182/bloodadvances.2020004079
Blood Advances; Kambhampati S, Sheng Y et. al.

Sep 21st, 2021 - B-cell maturation antigen-targeted chimeric antigen receptor T cell therapy (BCMA CAR-T) is an effective treatment for relapsed refractory multiple myeloma (RRMM). However the pattern of infectious complications is not well-elucidated. We performe...

Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (R...
https://doi.org/10.1016/j.clim.2021.108837
Clinical Immunology (Orlando, Fla.); Papa R, Rusmini M et. al.

Aug 30th, 2021 - RAS-associated autoimmune leukoproliferative disease (RALD) is a rare immune dysregulation syndrome caused by somatic gain-of-function mutations of either NRAS or KRAS gene in hematopoietic cells. We describe a 27-year-old patient presenting at 5 ...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  1 results

Improving the Diagnosis of Common Variable Immune Deficiency
https://clinicaltrials.gov/ct2/show/NCT02680652

Abstract: An increased susceptibility to bacterial and viral infections is the hallmark of explain the study rationale, primary immunodeficiencies (PID). The most common PID requiring treatment with Ig replacement (SCIg or IVIg) is Common Variable...

see more →

News  19 results

Antibiotic, Rituximab Together Cut ANCA-Vasculitis Serious Infection Risk
https://www.medscape.com/viewarticle/950765

May 7th, 2021 - The serious infection risk associated with rituximab treatment for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is high but can be offset by co-prescribing co-trimoxazole, data from a single-center, retrospective study re...

Risk for Hypogammaglobulinemia, Infections With Rituximab Increased in Pediatric Patients
https://www.medscape.com/viewarticle/949577

Apr 20th, 2021 - A quarter of children receiving treatment with rituximab developed hypogammaglobulinemia within 18 months of starting the drug, according to preliminary research shared at the annual scientific meeting of the Childhood Arthritis and Rheumatology R...

Novel Study Explores Link Between Primary Immunodeficiencies, Rheumatic Diseases
https://www.medscape.com/viewarticle/939605

Oct 22nd, 2020 - Fully 48% of patients with autoimmune rheumatic diseases who developed persistent hypogammaglobulinemia after initiating treatment with immunomodulatory agents harbored gene variants associated with inborn errors of immunity, according to the find...

Novel Study Explores Link Between Primary Immunodeficiencies, Rheumatic Diseases
https://www.staging.medscape.com/viewarticle/939605

Oct 22nd, 2020 - Fully 48% of patients with autoimmune rheumatic diseases who developed persistent hypogammaglobulinemia after initiating treatment with immunomodulatory agents harbored gene variants associated with inborn errors of immunity, according to the find...

IPD in children may be a signal of immunodeficiency
https://www.mdedge.com/clinicianreviews/article/209354/infectious-diseases/ipd-children-may-be-signal-immunodeficiency?channel=284
Bianca Nogrady

Oct 3rd, 2019 - Recurrent invasive pneumococcal disease in children could be a signal of underlying primary immunodeficiency, according to a systematic review published in JAMA Pediatrics. Coen Butters, BMed, DCH, of the Royal Children’s Hospital in Melbourne, an.

see more →